A transgender woman spent eight months chasing a cancer diagnosis while doctors kept asking about her human immunodeficiency virus (HIV) status and her gender instead of her actual symptoms.
Quick Take
- Major medical groups say cancer screening should follow the organs a patient has, not their gender identity.
- Transgender adults get screened for cervical and breast cancer far less often than cisgender adults.
- Patient Mia Inez Adams says her cancer diagnosis was delayed eight months while providers focused on her identity.
- Reviews call for clear, anatomy-based screening rules and better provider training to close the gap.
Doctors Now Look at Organs, Not Labels, to Guide Screening
The American College of Obstetricians and Gynecologists says the rule is simple. Any body part that needs screening should get screened, no matter how the patient identifies. The University of California, San Francisco gives doctors the same instruction. If a patient has an organ and meets the usual risk criteria, screening should happen regardless of hormone use. Both groups admit there is not enough data yet on whether transgender people face higher cancer risk overall.
This organ-based approach sounds straightforward on paper. A transgender man who still has a cervix needs Pap tests. A transgender woman who has not had chest surgery still needs breast checks. The problem is not the medical logic. The problem is getting patients through the clinic door in the first place, and keeping them coming back for follow-up care.
The Numbers Show a Wide Screening Gap
Research backs up the concern. One study found transgender patients were screened for cervical cancer at 56 percent, compared to 72 percent for cisgender patients. Breast screening showed an even bigger split, 33 percent versus 65 percent. These are not small statistical blips. They point to a large group of people walking around with unknown cancer risk simply because they skipped a test their cisgender neighbor got routinely.
A Mayo Clinic discussion on this topic laid out why screening rates lag so far behind. Dr. Elizabeth Cathcart-Rake said cancer prevention for gender-diverse patients works best when it is personalized around the anatomy and risk factors actually present, not assumptions tied to identity. She also pointed to a mix of practical barriers, including cost, past bad experiences with doctors, and plain discrimination.
One Patient’s Eight-Month Wait for a Diagnosis
Mia Inez Adams shared her own story during that same discussion. Her cancer diagnosis took eight months longer than it should have, partly because providers kept zeroing in on her HIV status and her transgender identity instead of her actual cancer symptoms. She also described repeated, unnecessary pregnancy tests and assumptions made about her sex life that had nothing to do with why she walked into the clinic.
Adams recalled a specific moment that stuck with her. A mammogram center handed her a form marked “women only,” and the paperwork accidentally revealed her transgender status to staff. The awkwardness that followed embarrassed everyone in the room. Small administrative choices like a single form can create real friction that pushes patients away from getting screened again.
Barriers Beyond the Exam Room
Doctors themselves admit gaps in their own training. A 2022 review found many primary care physicians simply do not know current breast and cervical screening guidelines for transgender patients, which likely worsens the disparity. Medical schools have historically skipped transgender health topics in their curriculum, leaving providers without the background to handle these visits with confidence or basic sensitivity.
A separate oncology commentary flagged something subtler but just as damaging. Educational pamphlets that only describe “men with prostate cancer” or “women with uterine cancer” quietly erase transgender and gender-diverse patients from the conversation entirely. Being misgendered during a cancer screening visit is not a minor social slight. Research links it to patients avoiding future care and to real mental health consequences.
What a Fix Could Look Like
A recent systematic review argues the fix is not complicated in theory. Build screening programs around anatomy and risk factors, standardize the paperwork, and train providers properly, and uptake should improve. Several other reviews echo the same conclusion. Nobody in the medical literature seriously disputes that organ-based screening is the right clinical standard.
The harder work is fixing the everyday friction points, mismatched intake forms, untrained front-desk staff, and doctors who ask about identity before they ask about symptoms. Getting the medicine right matters little if patients feel unwelcome before they ever reach the exam room. Closing that gap protects lives, and it starts with basic professionalism and competence, not politics.
Sources:
ascopubs.org, academic.oup.com, acog.org, pmc.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov
